Rebecca Taub
Pres., R&D, and CMO at Madrigal Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Madrigal Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Madrigal Pharmaceuticals Inc. June 25, 202498.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Madrigal Pharmaceuticals Inc. | Grant or award | +454 | — | — |
| Mar 6, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −491 | $431.94 | $212,083 |
| Jan 26, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −647 | $492.42 | $318,596 |
| Jan 20, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −2,238 | $490.77 | $1,098,343 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Option exercise | +240 | $15.80 | $3,792 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Option exercise | +18,410 | $15.80 | $290,878 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −40 | $545.79 | $21,832 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −960 | $512.02 | $491,539 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −200 | $551.24 | $110,248 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −960 | $513.12 | $492,595 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −937 | $514.63 | $482,208 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −1,578 | $515.82 | $813,964 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −521 | $516.81 | $269,258 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −2,044 | $517.84 | $1,058,465 |
| Jan 9, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −970 | $518.67 | $503,110 |
Questions about Rebecca Taub
What boards is Rebecca Taub on?
Rebecca Taub sits on the board of Madrigal Pharmaceuticals Inc.
How long has Rebecca Taub served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.